Cody C. Rounds
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cody C. Rounds has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Jovan G. Brankov
Illinois Institute of Technology (United States)
3 shared publications - Kenneth M. Tichauer
Lawson Research Institute, St. Joseph’s Health Care London, London, ON, Canada
3 shared publications Chengyue Li
Department of Biomedical Engineering, Illinois Institute of Technology, 3255 S Dearborn St, Chicago IL 60616, USA
2 shared publications- Divya Ravi
Department of Cell, Developmental and Cancer Biology, OHSU, Portland OR, USA 97201
2 shared publications - Kimberley S. Samkoe
Thayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA
2 shared publications - Summer L. Gibbs
Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97201, USA
2 shared publications
Latest Publications
- Open Access
Synchrotron diffraction reveals distinct collagen-associated distributions of EGFR-targeted antibody and affibody in pancreatic tumors
Tumor extracellular matrix may influence the distribution of targeted agents differently across molecular formats. We compared how an antibody and an affibody targeting the same receptor distribute relative to collagen-associated tissue structure in pancreatic tumors. Methods: Cetuximab-IRDye700DX, an epidermal growth factor receptor (EGFR)-targeted fluorescent antibody, and ABY-029, an EGFR-targeted fluorescent affibody, were co-administered intravenously to 12 athymic nude mice bearing orthotopic pancreatic tumors: eight AsPC-1 and four PANC-1. Tumors were harvested at 3 or 24 h after injection, with four AsPC-1 and two PANC-1 mice at each time. Fluorescence images from 21 tissue slices were registered to scanning synchrotron X-ray diffraction (XRD) maps to compare each agent’s distribution with local collagen-associated diffraction intensity. Results: Cetuximab–XRD correlations were negative in all 12 mice at every evaluated binning scale (100–400 µm; all adjusted P = 0.0039). Cohort-average correlations were more negative for cetuximab than ABY-029 at all four scales (paired adjusted P = 0.0137–0.0381). At 400 µm, mean correlations were −0.502 and −0.249, respectively. ABY-029 correlations did not differ significantly from zero after adjustment. Vehicle controls showed positive background fluorescence–XRD associations. Conclusions: Cetuximab exhibited consistent inverse spatial associations with collagen-associated diffraction and stronger cohort-average associations than ABY-029. These findings show that agents targeting the same receptor can differ in their relationships with local tissue structure and support spatially resolved assessment of tissue access when selecting molecular formats for imaging and therapy.
Open AccessSynchrotron diffraction reveals distinct collagen-associated distributions of EGFR-targeted antibody and affibody in pancreatic tumors
Tumor extracellular matrix may influence the distribution of targeted agents differently across molecular formats. We compared how an antibody and an affibody targeting the same receptor distribute relative to collagen-associated tissue structure in pancreatic tumors. Methods: Cetuximab-IRDye700DX, an epidermal growth factor receptor (EGFR)-targeted fluorescent antibody, and ABY-029, an EGFR-targeted fluorescent affibody, were co-administered intravenously to 12 athymic nude mice bearing orthotopic pancreatic tumors: eight AsPC-1 and four PANC-1. Tumors were harvested at 3 or 24 h after injection, with four AsPC-1 and two PANC-1 mice at each time. Fluorescence images from 21 tissue slices were registered to scanning synchrotron X-ray diffraction (XRD) maps to compare each agent’s distribution with local collagen-associated diffraction intensity. Results: Cetuximab–XRD correlations were negative in all 12 mice at every evaluated binning scale (100–400 µm; all adjusted P = 0.0039). Cohort-average correlations were more negative for cetuximab than ABY-029 at all four scales (paired adjusted P = 0.0137–0.0381). At 400 µm, mean correlations were −0.502 and −0.249, respectively. ABY-029 correlations did not differ significantly from zero after adjustment. Vehicle controls showed positive background fluorescence–XRD associations. Conclusions: Cetuximab exhibited consistent inverse spatial associations with collagen-associated diffraction and stronger cohort-average associations than ABY-029. These findings show that agents targeting the same receptor can differ in their relationships with local tissue structure and support spatially resolved assessment of tissue access when selecting molecular formats for imaging and therapy.
- Open Access
Deep learning-based identification and quantification of rare circulating hybrid cells in orthotopic pancreatic cancer models
Significance: Rare-cell identification in fluorescence microscopy remains challenging because targets are sparse and background varies between specimens. Combining specimen-specific fluorescence enrichment with image classification may enable efficient and more specific automated detection of rare cells. Aim: We developed a two-stage framework to identify and quantify candidate rare circulating hybrid neoplastic cells (CHCs, ECAD+/CD45+) in peripheral blood mononuclear cell (PBMC) preparations from tumor-bearing and tumor-naïve mice. Approach: PBMCs from 28 mice were imaged by multichannel fluorescence microscopy. Matched unstained samples established animal-specific ECAD and CD45 background distributions for candidate cell enrichment. Blinded multi-annotator consensus labels were used to train a convolutional neural network (CNN) from DAPI, ECAD, and CD45 image crops. Generalization was evaluated by leave-one-animal-out validation across 10 random initializations. Final classification used a 10-model ensemble, and rare-cell burden was compared between groups using negative-binomial regression with total segmented-cell count as an exposure. Results: Of the 1,065,512 segmented cells, enrichment retained 10,176 candidates (0.96%), reducing the search space by >99%. Four of five evaluable tumor-bearing animals showed reproducible held-out discrimination, with median quantified area under the receiver operator characteristic curve (AUROCs) of 0.918–0.951; one animal was a reproducible outlier (median AUROC, 0.338). Ensemble deployment identified 157.94 positive-consensus cells per 50,000 segmented cells in tumor-bearing animals versus 49.55 in controls. The estimated rare-cell rate was 3.15-fold higher in tumor-bearing animals (95% CI, 0.91–10.99; two-sided p=0.071; prespecified one-sided p=0.036). Conclusions: Specimen-specific fluorescence enrichment combined with supervised image classification reduced the cellular search space and enabled automated quantification of a rare CHC (ECAD+/CD45+) phenotypes. Cross-animal validation also identified specimen-specific generalization failure, highlighting the importance of biological-specimen-level validation.
Open AccessDeep learning-based identification and quantification of rare circulating hybrid cells in orthotopic pancreatic cancer models
Significance: Rare-cell identification in fluorescence microscopy remains challenging because targets are sparse and background varies between specimens. Combining specimen-specific fluorescence enrichment with image classification may enable efficient and more specific automated detection of rare cells. Aim: We developed a two-stage framework to identify and quantify candidate rare circulating hybrid neoplastic cells (CHCs, ECAD+/CD45+) in peripheral blood mononuclear cell (PBMC) preparations from tumor-bearing and tumor-naïve mice. Approach: PBMCs from 28 mice were imaged by multichannel fluorescence microscopy. Matched unstained samples established animal-specific ECAD and CD45 background distributions for candidate cell enrichment. Blinded multi-annotator consensus labels were used to train a convolutional neural network (CNN) from DAPI, ECAD, and CD45 image crops. Generalization was evaluated by leave-one-animal-out validation across 10 random initializations. Final classification used a 10-model ensemble, and rare-cell burden was compared between groups using negative-binomial regression with total segmented-cell count as an exposure. Results: Of the 1,065,512 segmented cells, enrichment retained 10,176 candidates (0.96%), reducing the search space by >99%. Four of five evaluable tumor-bearing animals showed reproducible held-out discrimination, with median quantified area under the receiver operator characteristic curve (AUROCs) of 0.918–0.951; one animal was a reproducible outlier (median AUROC, 0.338). Ensemble deployment identified 157.94 positive-consensus cells per 50,000 segmented cells in tumor-bearing animals versus 49.55 in controls. The estimated rare-cell rate was 3.15-fold higher in tumor-bearing animals (95% CI, 0.91–10.99; two-sided p=0.071; prespecified one-sided p=0.036). Conclusions: Specimen-specific fluorescence enrichment combined with supervised image classification reduced the cellular search space and enabled automated quantification of a rare CHC (ECAD+/CD45+) phenotypes. Cross-animal validation also identified specimen-specific generalization failure, highlighting the importance of biological-specimen-level validation.
- Open Access
Cyclic immunofluorescence platform using photocleavable linkers for direct antibody labeling enables cancer phenotyping
Advances in spatial proteomics through the development of multiplexed immunostaining platforms have facilitated analyses with increasing cellular and molecular granularity. However, currently available approaches are limited by harsh conditions for signal removal, restricting the number of antigens that can be probed in a single specimen without significant alterations to sample quality and structure. Here we present an approach for direct labeling of primary antibodies with fluorophores using a photocleavable linker (PCL) with a polyethylene glycol spacer (PEG) to enable cyclic immunofluorescence (cyCIF) with gentle signal removal conditions. Our innovative approach uses directly labeled primary antibodies to enhance staining specificity and cyclic immunostaining efficiency, while minimizing nonspecific background signal. Additionally, through integration of the PCL, this approach facilitates gentle cleavage of antibody conjugated fluorophore, preserving sample integrity over multiple rounds of staining. Direct PEG-PCL antibody labeling will promote greater multiplexing by minimizing specimen damage and allow for quantitative analyses of cyCIF spatial data. We demonstrate that cyCIF with PEG-PCL conjugated antibodies can be applied across a variety of cancer subtypes to identify and characterize rare neoplastic cell populations in both tumor tissue and fragile peripheral blood specimens.
Open AccessCyclic immunofluorescence platform using photocleavable linkers for direct antibody labeling enables cancer phenotyping
Advances in spatial proteomics through the development of multiplexed immunostaining platforms have facilitated analyses with increasing cellular and molecular granularity. However, currently available approaches are limited by harsh conditions for signal removal, restricting the number of antigens that can be probed in a single specimen without significant alterations to sample quality and structure. Here we present an approach for direct labeling of primary antibodies with fluorophores using a photocleavable linker (PCL) with a polyethylene glycol spacer (PEG) to enable cyclic immunofluorescence (cyCIF) with gentle signal removal conditions. Our innovative approach uses directly labeled primary antibodies to enhance staining specificity and cyclic immunostaining efficiency, while minimizing nonspecific background signal. Additionally, through integration of the PCL, this approach facilitates gentle cleavage of antibody conjugated fluorophore, preserving sample integrity over multiple rounds of staining. Direct PEG-PCL antibody labeling will promote greater multiplexing by minimizing specimen damage and allow for quantitative analyses of cyCIF spatial data. We demonstrate that cyCIF with PEG-PCL conjugated antibodies can be applied across a variety of cancer subtypes to identify and characterize rare neoplastic cell populations in both tumor tissue and fragile peripheral blood specimens.
- Open Access
- 29 March 2025
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 30 (04) , 046001-16
Dual-channel pulse-dye densitometry can enable correction of fluorescent targeted and control agent plasma input function differences for quantitative paired-agent molecular imaging: a simulation study
In recent years, paired-agent imaging (PAI) strategies have been explored owing to their ability to yield quantitative in vivo imaging of cell-surface receptors.1 – 3 PAI requires the administration of at least two imaging agents of similar blood and tissue kinetics where one agent is targeted to a biomolecule of interest and one is untargeted (the “control” agent). By measuring the dynamics of the control agent, non-specific accumulation of the targeted agent and variable targeted agent delivery (attributable to the variability of blood flow and vascular permeability among tissues, particularly cancerous tissues) can potentially be accounted for, allowing for more quantitative estimates of the targeted agent’s specific binding through the approximation of a quantity termed the “binding potential” (BP). BP is directly proportional to the concentration of an agent’s biomolecular target,4 and as such, the measurement of this quantity can give critical insight into the disease state and phenotype of a biological tissue. In the context of surgical oncology, BP mapping (compared with targeted agent distribution mapping) may enable improved discrimination between malignant and non-malignant tissue types.5,6
- 29 March 2025
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 30 (04) , 046001-16
Open AccessDual-channel pulse-dye densitometry can enable correction of fluorescent targeted and control agent plasma input function differences for quantitative paired-agent molecular imaging: a simulation study
In recent years, paired-agent imaging (PAI) strategies have been explored owing to their ability to yield quantitative in vivo imaging of cell-surface receptors.1 – 3 PAI requires the administration of at least two imaging agents of similar blood and tissue kinetics where one agent is targeted to a biomolecule of interest and one is untargeted (the “control” agent). By measuring the dynamics of the control agent, non-specific accumulation of the targeted agent and variable targeted agent delivery (attributable to the variability of blood flow and vascular permeability among tissues, particularly cancerous tissues) can potentially be accounted for, allowing for more quantitative estimates of the targeted agent’s specific binding through the approximation of a quantity termed the “binding potential” (BP). BP is directly proportional to the concentration of an agent’s biomolecular target,4 and as such, the measurement of this quantity can give critical insight into the disease state and phenotype of a biological tissue. In the context of surgical oncology, BP mapping (compared with targeted agent distribution mapping) may enable improved discrimination between malignant and non-malignant tissue types.5,6
- Open Access
- 1 January 2024
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 29 (01) , 016003-10
Improved intraoperative identification of close margins in oral squamous cell carcinoma resections using a dual aperture fluorescence ratio approach: first in-human results
Over 370,000 new cases of oral squamous cell carcinomas (OSCC) were reported in 2020.1 The primary treatment for these tumors is surgical resection. 2 Yet, owing to the complex anatomy of the head and neck, complete resection of primary tumors is challenging and inadequate margins are observed in up to 40% of cases.3 – 5 These include both positive margins (tumor within 1 mm of the edge of the resected specimen) and close margins (tumor between 1 and 5 mm of the edge of the resected specimen).6,7 In cases where inadequate margins are found (any thick), patients often require intensive adjuvant therapy8 because a secondary surgery is typically not possible due to altered anatomy or the proximity of vital structures. In either scenario, patient outcomes are generally worse than if clear margins were obtained on the initial surgery.9- 1 January 2024
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 29 (01) , 016003-10
Open AccessImproved intraoperative identification of close margins in oral squamous cell carcinoma resections using a dual aperture fluorescence ratio approach: first in-human results
Over 370,000 new cases of oral squamous cell carcinomas (OSCC) were reported in 2020.1 The primary treatment for these tumors is surgical resection. 2 Yet, owing to the complex anatomy of the head and neck, complete resection of primary tumors is challenging and inadequate margins are observed in up to 40% of cases.3 – 5 These include both positive margins (tumor within 1 mm of the edge of the resected specimen) and close margins (tumor between 1 and 5 mm of the edge of the resected specimen).6,7 In cases where inadequate margins are found (any thick), patients often require intensive adjuvant therapy8 because a secondary surgery is typically not possible due to altered anatomy or the proximity of vital structures. In either scenario, patient outcomes are generally worse than if clear margins were obtained on the initial surgery.9 - Open Access
- 19 October 2023
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 6 (5) , 427-432
A cadaveric breast cancer tissue phantom for phase‐contrast X‐ray imaging applications
Background: As mammography X-ray imaging technologies advance and provide elevated contrast in soft tissues, a need has developed for reliable imaging phantoms for use in system design and component calibration. In advanced imaging modalities such as refraction-based methods, it is critical that developed phantoms capture the biological details seen in clinical precancerous and cancerous cases while minimizing artifacts that may be caused due to phantom production. This work presents the fabrication of a breast tissue imaging phantom from cadaveric breast tissue suitable for use in both transmission and refraction-enhanced imaging systems.Methods: Human cancer cell tumors were grown orthotopically in nude athymic mice and implanted into the fixed tissue while maintaining the native tumor/adipose tissue interface.Results: The resulting human-murine tissue hybrid phantom was mounted on a clear acrylic housing for absorption and refraction X-ray imaging. Digital breast tomosynthesis was also performed.Conclusion: Both attenuation-based imaging and refraction-based imaging of the phantom are presented to confirm the suitability of this phantom's use in both imaging modalities.
- 19 October 2023
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 6 (5) , 427-432
Open AccessA cadaveric breast cancer tissue phantom for phase‐contrast X‐ray imaging applications
Background: As mammography X-ray imaging technologies advance and provide elevated contrast in soft tissues, a need has developed for reliable imaging phantoms for use in system design and component calibration. In advanced imaging modalities such as refraction-based methods, it is critical that developed phantoms capture the biological details seen in clinical precancerous and cancerous cases while minimizing artifacts that may be caused due to phantom production. This work presents the fabrication of a breast tissue imaging phantom from cadaveric breast tissue suitable for use in both transmission and refraction-enhanced imaging systems.Methods: Human cancer cell tumors were grown orthotopically in nude athymic mice and implanted into the fixed tissue while maintaining the native tumor/adipose tissue interface.Results: The resulting human-murine tissue hybrid phantom was mounted on a clear acrylic housing for absorption and refraction X-ray imaging. Digital breast tomosynthesis was also performed.Conclusion: Both attenuation-based imaging and refraction-based imaging of the phantom are presented to confirm the suitability of this phantom's use in both imaging modalities.